Peter Olupot-Olupot

Intravenous Rehydration for Severe Acute Malnutrition with Gastroenteritis.Maitland K, Ouattara SM, Sainna H, Chara A, Ogundipe OF, Sunyoto T, Hamaluba M, Olupot-Olupot P, Alaroker F, Connon R, Saidou Maguina A, Okiror W, Amorut D, Mwajombo E, Oguda E, Mogaka C, Langendorf C, Dewez JE, Ciglenecki I, Gibb DM, Coldiron ME, Petrucci R, George EC
N Engl J Med, (2025). :

Comparing HemoCue® and Quantitative Buffy Coat® and Coulter Counter-measured haemoglobin concentrations in African children with acute uncomplicated malaria: a Bland-Altman analysis.Ayuen DS, Olupot-Olupot P, Muhindo R, Onyamboko MA, Ajayi S, Chimjinda N, Taya C, Uyoga S, Williams TN, Maitland K, Fanello C, Day NPJ, Taylor WR, Mukaka M
Malar J, (2025). 24:77

Comparing HemoCue® and Quantitative Buffy Coat® and Coulter Counter-measured haemoglobin concentrations in African children with acute uncomplicated malaria: a Bland-Altman analysis.Ayuen DS, Olupot-Olupot P, Muhindo R, Onyamboko MA, Ajayi S, Chimjinda N, Taya C, Uyoga S, Williams TN, Maitland K, Fanello C, Day NPJ, Taylor WR, Mukaka M
Malar J, (2025). 24:77

Catastrophic expenditure associated with childhood hospitalisation for acute illness in Kenya and Uganda: a cross-sectional study.Jemutai J, Njuguna RG, Laurence YV, Murunga S, Ogwang C, Mwaringa S, Mwalekwa L, Timbwa M, Paasi G, Olupot-Olupot P, Juma M, Thitiri J, Ngao N, Singa B, Mukisa J, Mupere E, Lancioni C, Sukhtankar P, Tickell KD, Fakhar Uddin M, Molyneux S, Walson JL, Vassall A, Berkley J
BMJ Public Health, (2025). 3:e001173

Effect of nutritional supplementation with lipid-based therapeutic food on body composition of non-severely malnourished African children aged 6-59 months hospitalized with severe pneumonia.Nalwanga D, Musiime V, Kiguli S, Olupot-Olupot P, Alaroker F, Opoka R, Tagoola A, Mnjala H, Mogaka C, Nabawanuka E, Giallongo E, Karamagi C, Briend A, Maitland K
J Trop Pediatr, (2025). 71:

Azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a phase II randomised controlled trial.Connon R, Olupot-Olupot P, Pistorius AMA, Okiror W, Ssenyondo T, Muhindo R, Uyoga S, Mpoya A, Williams TN, Gibb DM, Walker AS, Ter Heine R, George EC, Maitland K
BMC Med, (2024). 22:516

Is fat mass a better predictor of 6-month survival than muscle mass among African children aged 6-59 months with severe pneumonia?.Nalwanga D, Musiime V, Kiguli S, Olupot-Olupot P, Alaroker F, Opoka R, Tagoola A, Mnjalla H, Mogaka C, Nabawanuka E, Giallongo E, Karamagi C, Briend A, Maitland K
BMC Nutr, (2024). 10:130

Legume-supplemented feed for children hospitalised with severe malnutrition: A Phase II trial.Walsh K, Kiosia A, Olupot-Oupot P, Alaroker F, Okiror W, Nakuya M, Ssenyondo T, Amorut D, Okalebo CB, Muhindo R, Mpoya A, George EC, Frost G, Maitland K
Br J Nutr, (2024). 132:372-381

Nutritional supplementation in children with severe pneumonia in Uganda and Kenya (COAST-Nutrition): a phase 2 randomised controlled trial.Kiguli S, Olupot-Olupot P, Hamaluba M, Giallongo E, Thomas K, Alaroker F, Opoka RO, Tagoola A, Oyella S, Nalwanga D, Nabawanuka E, Okiror W, Nakuya M, Amorut D, Muhindo R, Mpoya A, Mnjalla H, Oguda E, Williams TN, Harrison DA, Rowan K, Briend A, Maitland K
EClinicalMedicine, (2024). 72:102640

Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial.Aygun B, Lane A, Smart LR, Santos B, Tshilolo L, Williams TN, Olupot-Olupot P, Stuber SE, Tomlinson G, Latham T, Ware RE
Lancet Haematol, (2024). S2352-3026:00078-4

Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial.Aygun B, Lane A, Smart LR, Santos B, Tshilolo L, Williams TN, Olupot-Olupot P, Stuber SE, Tomlinson G, Latham T, Ware RE
Lancet Haematol, (2024). 11:e425-e435

Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial.Power-Hays A, Tomlinson GA, Tshilolo L, Santos B, Williams TN, Olupot-Olupot P, Smart LR, Aygun B, Lane A, Stuber SE, Latham T, Ware RE
Am J Hematol, (2024). 99:625-632

Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo.Onyamboko MA, Olupot-Olupot P, Were W, Namayanja C, Onyas P, Titin H, Baseke J, Muhindo R, Kayembe DK, Ndjowo PO, Basara BB, Okalebo CB, Williams TN, Uyoga S, Taya C, Bamisaiye A, Fanello C, Maitland K, Day NPJ, Taylor WRJ, Mukaka M
BMC Med, (2023). 21:397

Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria.Mukaka M, Onyamboko MA, Olupot-Olupot P, Peerawaranun P, Suwannasin K, Pagornrat W, Kouhathong J, Madmanee W, Were W, Namayanja C, Onyas P, Titin H, Baseke J, Muhindo R, Kayembe DK, Ndjowo PO, Basara BB, Bongo GS, Okalebo CB, Abongo G, Uyoga S, Williams TN, Taya C, Dhorda M, Dondorp AM, Waithira N, Imwong M, Maitland K, Fanello C, Day NPJ, Tarning J, White NJ, Taylor WRJ
EBioMedicine, (2023). 96:104805

Cardiovascular abnormalities in chest radiographs of children with pneumonia, Uganda.Nabawanuka E, Ameda F, Erem G, Bugeza S, Opoka RO, Kiguli S, Amorut D, Aloroker F, Olupot-Olupot P, Mnjalla H, Mpoya A, Maitland K
Bull World Health Organ, (2023). 101:202-210

Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial.Taylor WR, Olupot-Olupot P, Onyamboko MA, Peerawaranun P, Weere W, Namayanja C, Onyas P, Titin H, Baseke J, Muhindo R, Kayembe DK, Ndjowo PO, Basara BB, Bongo GS, Okalebo CB, Abongo G, Uyoga S, Williams TN, Taya C, Dhorda M, Tarning J, Dondorp AM, Waithira N, Fanello C, Maitland K, Mukaka M, Day NJP
Lancet Infect Dis, (2022). 23:471-483

Hydroxyurea is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa.Olupot-Olupot P, Tomlinson G, Williams TN, Tshilolo LMM, Santos B, Smart LR, McElhinney K, Howard TA, Aygun B, Stuber SE, Lane A, Latham T, Ware RE
Blood, (2022). 141:1402-1410

High false discovery rate of the Architect anti-HCV screening test in blood donors in Uganda and evaluation of an algorithm for confirmatory testing.Lucey O, Acana S, Olupot-Olupot P, Muhindo R, Ayikobua R, Uyoga S, Kyeyune-Byabazaire D, Cooke G, Maitland K
Vox Sang, (2022). 117:1360-1367

Sickle cell anaemia and severe Plasmodium falciparum malaria: a secondary analysis of the Transfusion and Treatment of African Children Trial (TRACT).Uyoga S, Olupot-Olupot P, Connon R, Kiguli S, Opoka RO, Alaroker F, Muhindo R, Macharia AW, Dondorp AM, Gibb DM, Walker AS, George EC, Maitland K, Williams TN
Lancet Child Adolesc Health, (2022). 6:606-613

A Clinical and Physiological Prospective Observational Study on the Management of Pediatric Shock in the Post-Fluid Expansion as Supportive Therapy Trial Era.Obonyo NG, Olupot-Olupot P, Mpoya A, Nteziyaremye J, Chebet M, Uyoga S, Muhindo R, Fanning JP, Shiino K, Chan J, Fraser JF, Maitland K
Pediatr Crit Care Med, (2022). 23:502-513